Athersys (Nasdaq: ATHX) is getting slammed in early trading following an update on its MultiStem Phase 2.Ahead of the opening ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE